Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Inhibition Of The Pi3k/Akt Signaling Pathway Increases Efficacy Of Doxorubicin And Its Derivative Ad198 In Bladder And Oral Cancers, Dmitriy Smolensky
Inhibition Of The Pi3k/Akt Signaling Pathway Increases Efficacy Of Doxorubicin And Its Derivative Ad198 In Bladder And Oral Cancers, Dmitriy Smolensky
Doctoral Dissertations
Doxorubicin (Dox) is a successful chemotherapy to treat various cancers, including bladder and oral cancers. Many patients initially respond to Dox-based regimens, however often cancers become resistant. A novel derivatives of Dox, e.g. N-benzyladriamycin-14-valerate (AD198), have been developed to overcome Dox-induced drug resistance and cardiotoxicity. The purpose of this thesis was to determine the efficacy of AD198 and Dox in bladder and oral cancers in vitro.
Part-I of this dissertation focuses on the bladder cancer, including discussing risk factors, diagnosis, staging, and current treatment options, following by a description of altered molecular mechanisms responsible cancer progression. This section also focuses …